跳至主要内容
临床试验/NCT04792658
NCT04792658Unknown不适用

Impact of Long Term of Benzodiazepine Use on Psychiatric Manifestation in Neuropsychiatric Disease

Assiut University0 个研究点目标入组 100 人开始时间: 2021年3月10日最近更新:
适应症

试验速览

阶段
不适用
入组人数
100
主要终点
measure of risk factor of DSM 5 psychiatric disorders associated with long term of benzodiazepine use

研究概览

简要总结

Benzodiazepines are usually a secondary drug of abuse-used mainly to augment the high received from another drug or to offset the adverse effects of other drugs. Few cases of addiction arise from legitimate use of benzodiazepines. Pharmacologic dependence, a predictable and natural adaptation of a body system long accustomed to the presence of a drug, may occur in patients taking therapeutic doses of benzodiazepines. However, this dependence, which generally manifests itself in withdrawal symptoms upon the abrupt discontinuation of the medication, may be controlled and ended through dose tapering, medication switching, and/or medication augmentation. Due to the chronic nature of anxiety, long-term low-dose benzodiazepine treatment may be necessary for some patients; this continuation of treatment should not be considered abuse or addiction.

previous study reported that The results of the study are important in that they corroborate the mounting evidence that a range of neuropsychological functions are impaired as a result of long-term benzodiazepine use, and that these are likely to persist even following withdrawal. The findings highlight the residual neurocognitive compromise associated with long-term benzodiazepine therapy as well as the important clinical implications of these results.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • age from 18 years to 50 years
  • No history of neurological or medical illness

排除标准

  • intelligence score more than 80

结局指标

主要结局

measure of risk factor of DSM 5 psychiatric disorders associated with long term of benzodiazepine use

时间窗: through study completion, an average of 1 year

measure the prevalence of DSM 5 psychiatric disorders associated with long term of benzodiazepine use

时间窗: through study completion, an average of 1 year

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Gellan Karamalllah Ramadan Ahmed

lecturer, resarcher OF Neurology and Psychiatry department

Assiut University

相似试验